Aureli Massimo

Mapping the Impact of ETI-mediated CFTR Reactivation On Development: a zebrafish model study / M. Cafora, S. Pagliughi, D. Dobi, G. Galassi, A. Mantero, M. Aureli, A. Pistocchi. ((Intervento presentato al 48. convegno European Cystic Fibrosis Conference : 4-7 June tenutosi a Milano nel 2025.

Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model / E. Chiricozzi, G. Lunghi, M. Valsecchi, E.V. Carsana, R. Bassi, E. Di Biase, D. Dobi, M.G. Ciampa, L. Mauri, M. Aureli, K. Inamori, J. Inokuchi, S. Sonnino, M. Fazzari. - In: BIOMEDICINES. - ISSN 2227-9059. - 13:4(2025 Apr), pp. 843.1-843.22. [10.3390/biomedicines13040843]

Ganglioside GD2 Contributes to a Stem‐Like Phenotype in Intrahepatic Cholangiocarcinoma / A. Mannini, M. Pastore, A. Giachi, M. Correnti, E. Spínola Lasso, T. Lottini, B. Piombanti, I. Tusa, E. Rovida, C. Coulouarn, J.B. Andersen, M. Lewinska, C. Campani, V.L. Battula, B. Yuan, M. Aureli, E.V. Carsana, C. Peraldo Neia, P. Ostano, A. Tani, D. Nosi, A. Vanni, L. Maggi, L. Di Tommaso, G. Comito, S. Madiai, A. Arcangeli, F. Marra, C. Raggi. - In: LIVER INTERNATIONAL. - ISSN 1478-3223. - 45:1(2025 Jan), pp. e16208.1-e16208.17. [10.1111/liv.16208]

Effect of CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor on lipid metabolism in human bronchial epithelial cells / D. Dobi, N. Loberto, L. Mauri, R. Bassi, E. Chiricozzi, G. Lunghi, M. Aureli. - In: GLYCOCONJUGATE JOURNAL. - ISSN 0282-0080. - 42:1(2025), pp. 1-14. [10.1007/s10719-024-10174-7]

Anti-inflammatory activity of Pseudomonas aeruginosa DEV phage in cystic fibrosis models / M. Cafora, D. Dobi, J.N.G. William, F. Forti, L. Belleri, N. Loberto, R. Bassi, S. Carbone, M. Locati, M. Aureli, F. Briani, A. Pistocchi. - In: JOURNAL OF CYSTIC FIBROSIS. - ISSN 1569-1993. - (2025), pp. 1-9. [Epub ahead of print] [10.1016/j.jcf.2025.03.001]